China's Angelalign H1 revenue rises on higher clear aligner case volume

Angelalign Technology

31/08/2026 12:13

Overview
China clear aligner maker's H1 2026 revenue rose 42.9% yr/yr
Adjusted net profit for H1 2026 grew 79.5% yr/yr
Company attributed growth to clinician recognition and investment in professional education

Outlook
Company did not provide specific financial guidance or forecasts for the current quarter or full year

Result Drivers
CLINICIAN RECOGNITION - Co said growing clinician recognition of its products and services drove business growth
PROFESSIONAL EDUCATION - Co cited significant investment in professional education and training as supporting market share gains and profitability
GLOBAL CASE AND PRICE GROWTH – Global clear-aligner sales rose 61.7%, driven by higher case volume and average selling prices as orthodontists prioritized clinical outcomes and service

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
Beat
$230.70 mln
$203.69 mln (1 Analyst)

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Angelalign Technology Inc. is HK$96.80, about 9.3% above its August 28 closing price of HK$88.55
The stock recently traded at 31 times the next 12-month earnings vs. a P/E of 34 three months ago

Reuters Recommended Reads
Aug 31 - China's HeartCare Medical H1 revenue surges on stroke segment growth
Aug 28 - China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Aug 28 - China's Zhaoke Ophthalmology H1 revenue rises

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)